rhIL-11 treatment produces a 2.5 to 11-fold increase in VWF mRNA in normal dogs but not in homozygous (VWF −/−) VWD dogs, thus identifying a mechanism for elevation of plasma VWF in vivo. Here, VWF is linked to von Willebrand disease (hereditary or acquired).